The Specificity and Patterns of Staining in Human Cells and Tissues of p16INK4a Antibodies Demonstrate Variant Antigen Binding

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Sawicka, Magdalena ^a   Pawlikowski, Jeffrey ^b   Wilson, Stephen ^a   Ferdinando, Dudley ^a   Wu, Hong ^c   Adams, Peter David ^b   Gunn, David Andrew ^a   Parish, William ^a  

^a UNILEVER RESEARCH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR SUPPRESSOR PROTEIN;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; PRIMARY IMMUNE RESPONSE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; RNA, SMALL INTERFERING; STAINING AND LABELING;

EID: 84872191096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053313     Document Type: Article

References (26)

1. Liggett WH Jr, Sirdansky D, (1998) Role of the p16INK4a tumor suppressor gene in cancer. J Clin Oncol 16(3): 1197-206.
2. Rocco JW, Sirdansky D, (2001) P16INK4A (MST-1/CDKN2/INK4a) in cancer progression. Experimental Cell Research 264: 42-55.
3. Okamoto A, Demetrick DJ, Spillare EA, Hagivara K, Hussain SP, et al. (1994) Mutations and altered expression of p16INK4 in human cancer Proc Natl Acad Sci USA. 91: 11045-11049.
4. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, et al. (2001) Overexpression of p16INK4A as a specific marker of dyplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92: 276-284.
5. Volgareva G, Zavalishina L, Andreeva Y, Frank G, Krutikova E, et al. (2004) Protein p16INK4a as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC cancer 4: 58.
6. Dray M, Russell P, Dalrymple C, Wallman N, Angus G, et al. (2005) P16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 37(2): 112-24.
7. Cuschieri K, Wentzensen N, (2008) Human papillomavirus mRNA and p16INK4a detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 17(10): 2536-45.
8. Zhu CQ, Shih W, Ling CH, Tsao MS, (2006) Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evolution. J Clin Pathol 59(8): 790-800.
9. Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, et al. (2007) Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Ann Surg Oncol 14(12): 3403-11.
10. Gould Rotheberg BE, Berger AJ, Molinaro AM, Subtil A, Krauthammer MO, et al. (2009) Melanoma prognostic model using tissue microarrays and genetic algorithms. J Clin Oncol 27(34): 5772-80.
11. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, et al. (1997) Abrogation of the Rb/p16INK4a tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 57(15): 3126-30.
12. Wang SS, Trunk M, Schiffman M, Herrero R, Sherman ME, et al. (2004) Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev 13: 1355-1360.
13. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 436(7051): 720-4.
14. Pavey S, Conroy S, Russell T, Gabrielli B, (1999) Ultraviolet radiation induces p16CDKN2A expression in human skin. Cancer Res 59: 4185-4189.
15. Marra DE, Simoncini T, Liao JK, (2000) Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21Waf1 and p27Kip1. Circulation 102(17): 2124-30.
16. Groeger AM, Caputi M, Esposito V, De Luca A, Bagella L, et al. (1999) Independent prognostic role of p16INK4a expression in lung cancer. J Thorac Cardiovasc Surg 118: 529-535.
17. Haller F, Agaimy A, Cameron S, Beyer M, Gunawan B, et al. (2010) Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosis. Histopathology. 56(3): 305-318.
18. Nilsson K, Landberg G, (2006) Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16INK4a in Rb-functional and Rb-inactivated tumor cells. Int J Cancer 118: 1120-1125.
19. McKenzie HA, Fung C, Becker TM, Irvine M, Mann GJ, et al. (2010) Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A. Hum Mutat 31: 692-701.
20. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, et al. (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375: 503-506.
21. Haller F, Lobke C, Ruschhaupt M, Cameron S, Schulten HJ, et al. (2008) Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). J Pathol. 215(3): 253-262.
22. Cheng Y, Lee S, Harn HJ, Chen CJ, Chang YC, et al. (2003) Prognostic prediction of the immunohistochemical expression of p53 and p16INK4a in resected non-small cell lung cancer. Eur J Cardiothorac Surg 23: 221-228.
23. Chen J, Chen Y, Chen C, Wang Y, (2001) Loss of p16INK4a and/or pRb protein expression in NSCLC An immunohistochemical and prognostic study. Lung Cancer 31: 163-170.
24. Lin H, Berry GJ, Sun Z, Fee WE Jr, (2006) Cyclin D1 and p16INK4a expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol 7: 1-7.
25. Soares de Sa BC, Fugimori ML, Ribeiro K, Neto JP, Neves RI, et al. (2009) Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas. Melanoma Research 19: 135-141.
26. Pilon C, Pistorello M, Moscon A, Altavilla G, Pagotto U, et al. (1999) Inactivation of the p16INK4a Tumor Suppressor Gene in Adrenocortical Tumors. J Clin Endocrinol Metab 84(8): 2776-2779.